These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 23891829
1. Effects of N-phenylpropyl-N'-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice. Sage AS, Oelrichs CE, Davis DC, Fan KH, Nahas RI, Lever SZ, Lever JR, Miller DK. Pharmacol Biochem Behav; 2013 Sep; 110():201-7. PubMed ID: 23891829 [Abstract] [Full Text] [Related]
2. The sigma receptor ligand N-phenylpropyl-N'-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice. Tapia MA, Sage AS, Fullerton EI, Judd JM, Hildebrant PC, Will MJ, Lever SZ, Lever JR, Miller DK. Psychopharmacology (Berl); 2020 Mar; 237(3):723-734. PubMed ID: 31822924 [Abstract] [Full Text] [Related]
3. N-phenylpropyl-N'-substituted piperazines occupy sigma receptors and alter methamphetamine-induced hyperactivity in mice. Miller DK, Park ES, Lever SZ, Lever JR. Pharmacol Biochem Behav; 2016 Mar; 150-151():198-206. PubMed ID: 27851908 [Abstract] [Full Text] [Related]
4. Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies. Matsumoto RR, Potelleret FH, Mack A, Pouw B, Zhang Y, Bowen WD. Pharmacol Biochem Behav; 2004 Apr; 77(4):775-81. PubMed ID: 15099923 [Abstract] [Full Text] [Related]
5. N-Phenylpropyl-N'-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice. Sage AS, Vannest SC, Fan KH, Will MJ, Lever SZ, Lever JR, Miller DK. ISRN Pharmacol; 2013 Apr; 2013():546314. PubMed ID: 24089641 [Abstract] [Full Text] [Related]
6. SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus. Rodvelt KR, Lever SZ, Lever JR, Blount LR, Fan KH, Miller DK. Pharmacol Biochem Behav; 2011 Feb; 97(4):676-82. PubMed ID: 21115033 [Abstract] [Full Text] [Related]
7. Effect of sigma ligands on the cocaine-induced convulsions in mice. Skuza G. Pol J Pharmacol; 1999 Feb; 51(6):477-83. PubMed ID: 10817525 [Abstract] [Full Text] [Related]
8. Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418. Lever JR, Miller DK, Fergason-Cantrell EA, Green CL, Watkinson LD, Carmack TL, Lever SZ. J Pharmacol Exp Ther; 2014 Oct; 351(1):153-63. PubMed ID: 25100754 [Abstract] [Full Text] [Related]
13. Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice. Matsumoto RR, McCracken KA, Friedman MJ, Pouw B, De Costa BR, Bowen WD. Eur J Pharmacol; 2001 May 11; 419(2-3):163-74. PubMed ID: 11426838 [Abstract] [Full Text] [Related]
17. Cocaine occupancy of sigma1 receptors and dopamine transporters in mice. Lever JR, Fergason-Cantrell EA, Watkinson LD, Carmack TL, Lord SA, Xu R, Miller DK, Lever SZ. Synapse; 2016 Mar 13; 70(3):98-111. PubMed ID: 26618331 [Abstract] [Full Text] [Related]
20. Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides. Matsumoto RR, McCracken KA, Pouw B, Zhang Y, Bowen WD. Neuropharmacology; 2002 Jun 13; 42(8):1043-55. PubMed ID: 12128006 [Abstract] [Full Text] [Related] Page: [Next] [New Search]